Similar Items: Inside Front Cover: Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment (View 2/2026)
- Quantitative mid-treatment imaging biomarkers for response prediction after radiotherapy in head and neck cancer: a systematic review and meta-analysis
- Back Cover: Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization (View 3/2026)
- Head-to-head comparison of Tc-MIP-1404 CZT SPECT/CT and Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study
- Head to head comparison of [Ga]Ga-FAPI-04 and [F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a prospective study
- Identifying genetics biomarkers in correlation with pathological and PSMA PET/CT characteristics in prostate cancer
- Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy